Skip to content
Medical Health Aged Care

RACGP backs expert calls for drug testing

Royal Australian College of GPs 2 mins read

The Royal Australian College of General Practitioners (RACGP) has backed calls for drug testing services to save lives at risk.

It comes following experts urging the Victorian Government to establish drug checking facilities to detect fentanyl and fentanyl analogs as well as a range of potentially deadly synthetic substances. Last year, the coroner recommended the Government adopt a checking system to tell users what substances their recreational drugs contained.

RACGP Alcohol and Other Drugs spokesperson Dr Hester Wilson said urgent action was needed.

“This common-sense measure will save lives,” she said.

“People using drugs, particularly opioid drugs such as heroin, are flying blind and risking their lives every day because no one can tell them whether what they are taking contains fentanyl, fentanyl analogs or other deadly substances. If it does contain fentanyl, two milligrams can be lethal depending on the person’s body size.

“There is no time to lose. Overseas, in countries like the United States, fentanyl is being added to a range of recreational drugs with devastating results. Australia must brace itself, because the Australian Federal Police has seized huge shipments of fentanyl entering Australia.

“As things stand, we only establish whether a batch of drugs contains other hazardous substances at morgues or police seizures after people have already overdosed. By setting up drug testing centres, people can learn what the drugs they are taking contain before it’s too late.

“The centres will not tell people that the drugs they are taking are safe. Instead, the testing will reveal what many people taking these drugs will be all too aware of – that they cannot trust what they are being sold and that they are playing a dangerous game. It’s a lottery as to whether the opioid drugs you have bought contain fentanyl, you simply will not be able to determine this until it’s too late.

“So, let’s get on the front foot, and act decisively to protect people in the community before the situation worsens. Fentanyl is arriving on our shores and, given how addictive this substance is, I fear that once it gains a foothold in Australia there will be no turning back. Every life matters and this reform will save lives.”

A recent report from the National Drug and Alcohol Research Centre found that there were 1,788 drug-induced deaths Australia-wide in 2021, which is the equivalent of five drug-induced deaths every day. Natural and semi-synthetic pharmaceutical opioids including morphine and oxycodone are the primary opioids involved in overdose deaths, followed by heroin.

~ENDS

RACGP spokespeople are available for comment.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) was established in 1958 and is Australia’s peak general practice representative organisation.

The RACGP has more than 45,000 members working in or towards a career in general practice across metropolitan, regional, and rural areas of the country. Nine in every 10 GPs are with the RACGP.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Email: [email protected] (we will respond promptly).

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 10/03/2026
  • 16:28
Phebra

Phebra launches Rapiblyk® in Australian healthcare settings

Australian Pharmaceutical company Phebra (‘Company’) has announced the launch of Rapiblyk® (landiolol hydrochloride), an ultra‑short‑acting, cardio-selective receptor antagonist, indicated for rapid control of ventricular rate in patients with severe, acute cardiac arrhythmias (irregular rapid heart rate) in critical care settings. Clinical studies have demonstrated that Rapiblyk® enables safe, effective heart rate control with limited impact on blood pressure and inotropy (heart contractility). Rapiblyk® has a very short half life delivering a fast onset and offset of action. This provides clinicians with a higher level of precision in life-threatening situations. Phebra CEO Andre Vlok highlighted how Rapiblyk® strengthens the company's critical…

  • Medical Health Aged Care
  • 10/03/2026
  • 16:09
Dementia Australia

On this weekend – Memory Walk & Jog Adelaide!

The 2026 Adelaide Memory Walk & Jog is fast approaching, with the much-anticipated event taking place this weekend on Sunday 15 March at Wigley Reserve, Glenelg. With the big day kicking off at 7:30am, we welcome everyone in the Adelaide community to join their fellow participants as they walk, jog or run for better brain health and to help raise money in support of people living with dementia, their families and carers.Join MC Mark Gibson for a wonderful fun, family friendly day out. More than 960 people have already signed-up to take part – but there’s always room for more…

  • Contains:
  • Medical Health Aged Care
  • 10/03/2026
  • 16:01
Dementia Australia

Memory Walk & Jog Illawarra just weeks away!

The 2026 Illawarra Memory Walk & Jog is only a few short weeks away, with the event taking place on Sunday 22 March at Lang Park. Memory Walk & Jog returns to Illawarra in 2026, bringing the community together to get active for brain health and to show support for people impacted by dementia. Illawarra Memory Walk & Jog is a key Dementia Australia community event, helping raise funds to deliver invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported. Participants…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.